<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33540">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02010619</url>
  </required_header>
  <id_info>
    <org_study_id>BDD RCT</org_study_id>
    <nct_id>NCT02010619</nct_id>
  </id_info>
  <brief_title>Internet Delivered CBT for Body Dysmorphic Disorder</brief_title>
  <official_title>Internet Delivered Cognitive Behavior Therapy for Body Dysmorphic Disorder - a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Karolinska Institutet</source>
  <oversight_info>
    <authority>Sweden: Regional Ethical Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate if Internet delivered cognitive behavior therapy is an efficacious treatment
      when compared to a control group consisting of supportive therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <primary_completion_date type="Anticipated">January 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Body Dysmorphic Disorder Modification of the Y-BOCS (BDD-YBOCS)</measure>
    <time_frame>Change in BDD-YBOCS from baseline (week 0) to post-treatment (week 12)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Montgomery Åsberg Depression Rating Scale - self report (MADRS-S)</measure>
    <time_frame>Change in MADRS-S from baseline (week 0) to post-treatment (week 12)</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Body Dysmorphic Disorder</condition>
  <condition>BDD</condition>
  <arm_group>
    <arm_group_label>Cognitive behavior therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Supportive therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive behavior therapy</intervention_name>
    <arm_group_label>Cognitive behavior therapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Supportive therapy</intervention_name>
    <arm_group_label>Supportive therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  outpatient

          -  ≥ 18 years

          -  primary diagnosis of BDD according to the DSM-5

          -  BDD-YBOCS ≥20

          -  regular access to a computer with Internet access and skills to use the web.

        Exclusion Criteria:

          -  psychotropic medication changes within two months prior to the treatment,

          -  completed CBT for BDD within the last 12 months,

          -  other primary axis I diagnosis

          -  current substance dependence

          -  lifetime bipolar disorder or psychosis

          -  suicidal ideation

          -  Axis II diagnosis that could jeopardize treatment participation,

          -  other current psychological treatment that could affect BDD symptoms

          -  A serious medical illness that precludes participation in the study
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Christian Rück, M.D, Ph.D.</last_name>
    <email>christian.ruck@ki.se</email>
  </overall_contact>
  <location>
    <facility>
      <name>M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst</name>
      <address>
        <city>Stockholm</city>
        <state>Huddinge</state>
        <zip>141 86</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christian Rück, M.D., Ph.D</last_name>
      <phone>+46(0)70484 33 92</phone>
      <email>christian.ruck@ki.se</email>
    </contact>
    <investigator>
      <last_name>Christian Rück, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Sweden</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 12, 2013</lastchanged_date>
  <firstreceived_date>November 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Karolinska Institutet</investigator_affiliation>
    <investigator_full_name>Christian Rück</investigator_full_name>
    <investigator_title>Associate professor, M.D.</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Body Dysmorphic Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
